Intuitive Surgical’s first-quarter 2026 results reveal a nuanced international landscape, characterized by strong overall Outside U.S. (OUS) procedure growth but emerging pockets of weakness specifically in China and Japan. In China, management identifies slower tender activity, intensified pricing pressure, and rising competition from domestic manufacturers...
Shares of Intuitive Surgical (ISRG) have gained 4% over the past four weeks to close the last trading session at $470.99, presenting analysts with a mean price target estimate of $589 that suggests a potential upside of approximately 25.1%. The consensus figure is derived from...
Intuitive Surgical Inc (NASDAQ: ISRG) has emerged as a notable candidate under a screening strategy that combines fundamental analysis with technical setups to identify high-potential growth stocks. This approach prioritizes companies demonstrating robust revenue and earnings growth alongside solid financial health, while simultaneously seeking specific...
Intuitive Surgical reported first quarter results for fiscal year 2026 that exceeded Wall Street expectations, driven by robust global procedure growth and the expansion of its da Vinci and Ion robotic platforms. CEO David Rosa highlighted a 17% increase in total procedures, attributing this growth...
Intuitive Surgical (ISRG) reported strong Q1 2026 non-GAAP earnings, posting EPS of $2.50 against a consensus of $2.11, while revenue reached $2.77 billion, representing a 23% year-over-year increase. The company successfully placed 431 new da Vinci robotic systems during the quarter, including 232 units of...
